Trial Identifier: | D9570C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04931654 |
Start Date: | September 2021 |
Primary Completion Date: | July 2025 |
Study Completion Date: | July 2025 |
Condition: | Lung Cancer; Gastric Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
CA, ON | Toronto, ON, CA, M5G 2M9 |
CN | Beijing, CN, 100142 |
CN | Guangzhou, CN, 510060 |
ES | Barcelona, ES, 08035 |
ES | Madrid, ES, 28027 |
FR | Bordeaux, FR, 33076 |
FR | Villejuif Cedex, FR, 94805 |
JP | Chuo-ku, JP, 104-0045 |
JP | Kashiwa, JP, 277-8577 |
NL | Amsterdam, NL, 1066 CX |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
TR | Adana, TR, 01060 |
US, GA | Atlanta, GA, US, 30322 |
US, IN | Fort Wayne, IN, US, 46804 |
US, NY | New York, NY, US, 10029 |
US, TN | Nashville, TN, US, 37203 |